CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $14,000 | +40.0% | 410 | 0.0% | 0.00% | – |
Q1 2021 | $10,000 | -16.7% | 410 | 0.0% | 0.00% | – |
Q4 2020 | $12,000 | +71.4% | 410 | +13.9% | 0.00% | – |
Q3 2020 | $7,000 | -36.4% | 360 | 0.0% | 0.00% | – |
Q2 2020 | $11,000 | -96.0% | 360 | -93.9% | 0.00% | -100.0% |
Q4 2019 | $278,000 | – | 5,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |